Tech Support Scam

Business

Trane Technologies Caps Strong 2025 with Record Backlog, Bullish 2026 Outlook Despite Residential Headwinds

Trane Technologies (NYSE: TT) reported robust Q4 2025 results, driven by exceptional commercial HVAC demand and a record $7.8 billion backlog. While proactive inventory adjustments pressured residential margins, executives project 12-14% adjusted EPS growth for 2026, fueled by strategic acquisitions and sustained commercial strength.

Jan 30, 2026

Business

Carpenter Technology Soars on Aerospace Demand, Posts Record Q2 Profit and Raises Outlook

Driven by surging demand in aerospace and defense, Carpenter Technology (CRS) announced record-breaking quarterly profitability and raised its full-year forecast, citing constrained supply and favorable long-term pricing agreements.

Jan 30, 2026

Business

Fortive's Stock Slump Sparks Valuation Debate: Is the Industrial Tech Firm a Bargain?

Fortive Corporation's shares have retreated over 5% in the past month, prompting investors to re-examine the industrial technology conglomerate's fundamentals. With a renewed focus on its recurring revenue streams and a fair value estimate suggesting upside, analysts are divided on whether the pullback presents a buying opportunity or reflects deeper sector headwinds.

Jan 30, 2026

Business

Arlo Technologies Files ESOP Shelf Registration: A Strategic Move Amid Valuation Questions

Arlo Technologies has registered over 4.2 million shares for an employee stock plan, a move that brings potential dilution and the company's capital strategy into focus as its stock shows signs of cooling momentum after a strong run.

Feb 2, 2026

Business

Beyond the Rally: Three Tech Stocks Poised for Growth in a Volatile 2026 Market

As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.

Feb 2, 2026

Business

CapWealth Makes Bold Bet on Lumen Technologies with $10 Million Share Purchase

Investment firm CapWealth Advisors has significantly increased its stake in telecom provider Lumen Technologies, signaling confidence amid the company's strategic pivot towards enterprise and AI infrastructure.

Feb 2, 2026

Business

Spider Silk Meets Selvedge: AMSilk's Biotech Breakthrough Weaves Into Luxury Denim

German biotech firm AMSilk partners with Italian mill Pure Denim to launch a new category of high-performance, sustainable denim infused with lab-grown spider silk proteins, targeting the luxury market with enhanced comfort and eco-credentials.

Feb 2, 2026

Business

Following the Money: Three Tech Stocks in Focus After Pelosi's $69 Million Portfolio Reshuffle

Recent financial disclosures reveal significant repositioning by Speaker Emerita Nancy Pelosi and her husband in tech giants Nvidia, Apple, and Alphabet, sparking investor interest in their strategy of locking in gains while maintaining bullish exposure.

Feb 2, 2026

World

Inside the Abandoned Scam Fortress: Thai Military Reveals Sophisticated Operation at Cambodian Border

Thai troops now occupy a shell-damaged compound in O'Smach, Cambodia, which officials identify as a former hub for international scam operations. A military-led tour revealed a labyrinth of soundproofed call centers, fake police stations, and meticulous scripts, shedding light on a multi-billion dollar criminal enterprise.

Feb 2, 2026

Business

Cathie Wood Doubles Down on Tech Bets, Scoops Up Amazon, Robinhood, and Coinbase Shares

Ark Invest's founder bolstered positions in key holdings across e-commerce, fintech, and cryptocurrency sectors ahead of major earnings reports, signaling confidence amidst market volatility.

Feb 2, 2026

Business

Scholar Rock's Soaring Stock: Is the Biotech's Momentum Justified or Overheated?

Shares of clinical-stage biotech Scholar Rock (NASDAQ: SRRK) have surged nearly 60% in three months, closing at $44.34. This rally, backed by promising clinical progress, has investors weighing its premium valuation against its long-term potential in treating serious diseases.

Feb 2, 2026

Business

Analysts See Long-Term Promise in Legend Biotech's Carvykti Despite Fourth-Quarter Sales Shortfall

While Legend Biotech's CAR-T therapy Carvykti missed Q4 sales estimates, prompting mixed analyst reactions, some firms emphasize its curative potential and view the stock's recent decline as a strategic entry point for investors.

Feb 2, 2026

Business

Why Micron Technology Became Ashva Capital's Crown Jewel: A Bet on Memory's Future

Investment firm Ashva Capital Management reveals Micron Technology as its largest holding in its latest investor letter, detailing a conviction play on the memory chip giant's long-term trajectory amid AI-driven demand and market volatility.

Feb 2, 2026

From Alley to Empire: Three Decades On, New York's Tech Scene Has Outgrown Its Moniker

A recent anniversary event for 'Silicon Alley' highlighted how New York's technology sector has evolved from a concentrated downtown community into a vast, decentralized force spanning finance, AI, and e-commerce.

Feb 2, 2026

Business

Giverny Capital Trims Position in AMETEK, Citing Valuation Concerns Amid Tech Frenzy

Investment firm Giverny Capital Asset Management reduced its stake in industrial manufacturer AMETEK in Q4 2025, highlighting a disciplined approach to valuation as markets remain captivated by AI narratives. The firm's portfolio underperformed major indices, pressured by its underweight stance in mega-cap technology.

Feb 2, 2026

Business

Schweiter Technologies: A Volatile Swiss Small-Cap at a Premium

Schweiter Technologies (SWTQ) has seen significant price swings on the SIX Swiss Exchange. With its current valuation trading well above industry peers, we examine whether the stock's optimistic growth prospects justify the premium or if investors should wait for a better entry point.

Feb 2, 2026

Business

Beyond the Volatility: Three Tech Stocks Poised for Growth in a Shifting Market

Amidst a mixed economic backdrop, we spotlight three U.S. tech companies—Rumble, Daktronics, and Sandisk—whose strategic initiatives and robust growth projections set them apart for investors looking beyond near-term turbulence.

Feb 2, 2026

Business

Rhythm Pharmaceuticals: The Under-the-Radar Biotech Outpacing Tech Giants

While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.

Feb 2, 2026

Business

Marvell Technology's Steep Slide Tests Institutional Patience: Could Major Shareholders Force a Reckoning?

With its stock down 30% over the past year and a fresh 3.5% drop last week, Marvell Technology faces mounting pressure from its powerful institutional base, which controls 81% of the company. Analysts warn that continued underperformance could trigger a wave of selling, impacting all investors.

Feb 2, 2026

World

China Executes Four Over Deadly Myanmar Scam Empire, Intensifying Regional Crackdown

Chinese courts have executed four individuals convicted of running a multi-billion dollar scam and gambling network from Myanmar, responsible for multiple deaths. The move signals Beijing's escalating pressure on Southeast Asia's industrial-scale cybercrime hubs.

Feb 2, 2026